Dr. Subhashis Pal is a biomedical scientist specializing in endocrinology, bone biology, osteoimmunology, cancerimmunology, and microbiome research, with over a decade of experience spanning academia and industry. He currently serves as Senior Research Scientist at Eris Lifesciences, where he leads translational R&D programs in endocrine and metabolic therapeutics. Dr. Pal completed his Ph.D. in Biological Sciences from Jawaharlal Nehru University–CSIR-CDRI, focusing on phosphodiesterase inhibitors as bone anabolic targets. His postdoctoral training at Emory University under Dr. Roberto Pacifici established his expertise in the microbiome–immune–bone axis, uncovering mechanisms by which gut microbiota regulate PTH action, fracture healing, and bone metastasis. His research integrates immunometabolism, preclinical pharmacology, and mechanism-of-action studies using advanced in vivo models, including OVX, fracture, diabetes, and germ-free systems. He has authored over 50 publications in high-impact journals such as JCI, ACS Applied Materials & Interfaces, and Calcified Tissue International. Dr. Pal is the recipient of several prestigious honors, including the ASBMR President’s Award and the ECTS Early Career Award. He also serves as a peer reviewer for more than 39 international journals and actively contributes to collaborative, multidisciplinary research initiatives.